Improve balance using gamified exercise

Trial ID
NCT06538298
Official Title
A Multimodal Exercise Program With Gamification (MEP+G) in Individuals With Parkinson Disease: a Pilot Randomized Controlled Trial
Goal
Improve balance using gamified exercise
Phase
EARLY_PHASE1
Status
RECRUITING
Sponsor
California State University, Northridge
Study Type
INTERVENTIONAL
Enrollment
50 participants
Conditions
Parkinson Disease
Interventions
Multimodal Exercise Program with Gamification

Plain-Language Summary

The goal is to see if a structured, multimodal exercise program with game-like features can improve mobility, balance, endurance, and daily function in people with Parkinson's, possibly lowering fall risk and easing symptom burden. The program combines aerobic, strength, balance, and flexibility exercises with gamification elements like interactive feedback and challenges to boost motivation and adherence, and it aims to strengthen muscles and support brain circuits involved in movement as a complement to medications like levodopa, not a replacement. Eligible participants are adults 40 to 80 with idiopathic Parkinson's at Hoehn and Yahr stages 1,3 who can walk and stand for 10 minutes, have stable Parkinson's meds for at least 3 months, can get medical clearance and travel to the site, and who are not already doing more than 60 minutes per week of moderate to vigorous exercise, in Rock Steady boxing, living with another neurological disease, or within 3 months of deep brain stimulation.

Locations

  • Equilibrium Physical Therapy, Ventura, California, United States

Frequently Asked Questions

What is this trial testing?
This trial is studying Multimodal Exercise Program with Gamification. The goal is to see if a structured, multimodal exercise program with game-like features can improve mobility, balance, endurance, and daily function in people with Parkinson's, possibly lowering fall risk and easing symptom burden. The program combines aerobic, strength, balance, and flexibility exercises with gamification elements like interactive feedback and challenges to boost motivation and adherence, and it aims to strengthen muscles and support brain circuits involved in movement as a complement to medications like levodopa, not a replacement. Eligible participants are adults 40 to 80 with idiopathic Parkinson's at Hoehn and Yahr stages 1,3 who can walk and stand for 10 minutes, have stable Parkinson's meds for at least 3 months, can get medical clearance and travel to the site, and who are not already doing more than 60 minutes per week of moderate to vigorous exercise, in Rock Steady boxing, living with another neurological disease, or within 3 months of deep brain stimulation.
Who can participate?
Participants must be between 40 Years and 80 Years.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
No. There is no cost to participate. Study-related care and treatment are provided at no charge.
How long does the trial last?
This Phase 1 trial is estimated to last approximately 1 year and 8 months.

View on ClinicalTrials.gov